Leah Durant
SIRVA
FDA Approves New Meningococcal Vaccine, MenQuadfi, Manufactured by Sanofi Pasteur, Inc.
The U.S. Food and Drug Administration (FDA) has approved a new meningococcal vaccine for use in the United States. The new vaccine, MenQuadfi, is manufactured by pharmaceutical giant Sanofi Pasteur, Inc. MenQuadfi joins five other meningococcal vaccines that are currently approved for use in the U.S.: Menveo, Menactra, BEXSERO, TRUMENBA and Menomune-A/C/Y/W-135. It is indicated … Continue reading
How Long Do You Have to Seek Financial Compensation for SIRVA?
If you have been diagnosed with brachial neuritis, shoulder bursitis or any other type of shoulder injury related to vaccine administration (SIRVA), there is a lot you need to know. From dealing with unexpected medical bills to coping daily with chronic pain and physical limitations, a SIRVA diagnosis can impact nearly all aspects of your … Continue reading
A Comprehensive Review of Our VICP Claim Results in 2019
At the Law Offices of Leah V. Durant, PLLC, our practice is devoted to representing individuals and families in vaccine injury claims under the National Vaccine Injury Compensation Program (VICP). Each year, we handle hundreds of claims, and we recover millions of dollars in compensation for our clients’ medical expenses, lost wages, and pain and … Continue reading
Reducing the Risk of SIRVA (and Its Long-Term Complications)
With a recent report concluding that vaccination errors account for more than half of all vaccine-related injuries, it is important for individuals who are getting vaccinated to be aware of the steps they (and their healthcare providers) can take to reduce the risk of shoulder injuries related to vaccine administration (SIRVA). Understanding Shoulder Injuries Related … Continue reading
Is it Possible to Get Sick from the Flu Shot?
If you have heard of people getting sick shortly after getting the flu shot, you are not alone. It is a common misconception that the flu shot can cause influenza – so common, in fact, that the Centers for Disease Control and Prevention (CDC) has found it necessary to dispel the rumor on its website: … Continue reading
Total VICP Payments Surpassed $4 Billion in Early 2019
The National Vaccine Injury Compensation Program (VICP) is a federal government program that provides a source of financial recovery for individuals who have been diagnosed with vaccine-related injuries and illnesses. While all vaccine-related injuries and illnesses are eligible for compensation under the VICP, most cases involve what are known as “on-table” injuries – medical conditions … Continue reading
New Study Confirms Flu Shot More Effective Than Prior Nasal Spray Vaccine
When the Centers for Disease Control and Prevention (CDC) re-approved use of the nasal spray flu vaccine for the 2018-2019 flu season, the American Academy of Pediatrics (AAP) issued a recommendation that the nasal spray vaccine only be used as a “last resort” due to its low rate of effectiveness in prior years. Now, a … Continue reading
The Reveal: News Investigation Reveals Alarming Facts about SIRVA
“Shoulder injuries related to vaccine administration,” or “SIRVA,” are potentially-serious injuries that result from errors during immunizations. While vaccines themselves can be harmful in some circumstances (i.e. when administered to someone who is allergic to a vaccine ingredient), an examination of recent claims filed under the National Vaccine Injury Compensation Program (VICP) revealed that about … Continue reading
CDC and the National Foundation for Infectious Diseases (NFID) Kick Off 2018–2019 Flu Vaccination Campaign
The Centers for Disease Control and Prevention (CDC) and the National Foundation for Infectious Diseases (NFID) encourage flu vaccination for everyone six months of age and older unless otherwise advised by their doctors. Although the flu shot’s overall effectiveness varies from year to year, the CDC states that getting immunized is the best way for … Continue reading
FDA Approves Expanded Use of Afluria and Afluria Quadrivalent Flu Vaccines
In late 2018, the U.S. Food and Drug Administration (FDA) announced expanded approval of the Afluria and Afluria Quadrivalent flu vaccines. Previously approved for adults and children five years of age and older, the FDA’s expanded approval for Afluria and Afluria Quadrivalent now makes these vaccines available to children beginning at six months of age. … Continue reading
Find Out More On Social Media
